The NVX-CoV2373 vaccine (Novavax) consists of full-length, prefusion, recombinant spike (rS) protein trimers with epitopes conserved across variants and is coformulated with a saponin-based ...

Novonix (NASDAQ:NVX) is advancing both its Cathode and Anode materials units as it continues its strategy to develop a north American supply chain to support the battery industry. With Novonix ...

Research reports the results of a phase 3 clinical trial evaluating the safety, immunogenicity, and efficacy of the NVX-CoV2373 vaccine in adolescents aged 12 to 17 years.

Technology company Novonix (NASDAQ:NVX) is developing a local battery materials supply chain for North America. Tariffs and international trade prospects shine a light, we believe, on the need for ...

However, that's not what’s interesting about NVX as revenues from their Battery Technology Solutions division have been flat for years. Net income has bounced around the negative $50m mark over ...